Differentiation renders susceptibility to excitotoxicity in HT22 neurons

Neural Regeneration Research

Volumn 8, Issue 14, 2013, Pages 1297-1306

  He, Minchao ^a,b   Liu, Jun ^a,b   Cheng, Shaowu ^b   Xing, Yigang ^a   Suo, William Z ^b,c  

^a SUN YAT SEN UNIVERSITY   (China)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Brain injury; Differentiation; Excitatory neurotoxicity; Glutamate; Grants supported paper; Hippocampus; HT22; Memantine; Mitosis; MK 801; N methyl D aspartate receptor; Neural regeneration; Neurons; Neuroregeneration

Indexed keywords

CHOLINERGIC RECEPTOR; DITHIOTHREITOL; DIZOCILPINE; GLUTAMATE RECEPTOR; GLUTAMIC ACID; HOE 33342; LACTATE DEHYDROGENASE; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; PROPIDIUM IODIDE;

ANIMAL CELL; ARTICLE; CELL DAMAGE; CELL DIFFERENTIATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; EXCITOTOXICITY; HIPPOCAMPAL NEURON; HIPPOCAMPAL NEURONAL CULTURE; METHYL THIAZOLYL TETRAZOLIUM ASSAY; MOUSE; NERVE CELL; NONHUMAN; OXIDATIVE STRESS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 84889874069     PISSN: 16735374     EISSN: 18767958     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Okubo Y, Sekiya H, Namiki S, et al. Imaging extrasynaptic glutamate dynamics in the brain. Proc Natl Acad Sci U S A. 2010;107(14):6526-6531.
2. Takeuchi A. The transmitter role of glutamate in nervous systems. Jpn J Physiol. 1987;37(4):559-572.
3. Olney JW, de Gubareff T. Glutamate neurotoxicity and Huntington's chorea. Nature. 1978;271(5645):557-559.
4. Lau A, Tymianski M. Glutamate receptors, neurotoxicity and neurodegeneration. Pflugers Arch. 2010;460(2): 525-542.
5. Chhunchha B, Fatma N, Kubo E, et al. Curcumin abates hypoxia-induced oxidative stress based-ER stress-mediated cell death in mouse hippocampal cells (HT22) by controlling Prdx6 and NF-kappaB regulation. Am J Physiol Cell Physiol. in press.
6. Guo F, Wang H, Li L, et al. A novel domain of Amino-Nogo-A protects HT22 cells exposed to oxygen glucose deprivation by inhibiting NADPH oxidase activity. Cell Mol Neurobiol. in press.
7. Doria JG, Silva FR, de Souza JM, et al. Metabotropic glutamate receptor 5 positive allosteric modulators are neuroprotective in a mouse model of Huntington's disease. Br J Pharmacol. in press.
8. Hu NW, Ondrejcak T, Rowan MJ. Glutamate receptors in preclinical research on Alzheimer's disease: update on recent advances. Pharmacol Biochem Behav. 2012; 100(4):855-862.
9. Choi DW. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1988;1(8):623-634.
10. Choi DW. Glutamate neurotoxicity in cortical cell culture is calcium dependent. Neurosci Lett. 1985;58(3):293-297.
11. Sattler R, Xiong Z, Lu WY, et al. Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein. Science. 1999;284(5421):1845-1848.
12. Cao G, Xing J, Xiao X, et al. Critical role of calpain I in mitochondrial release of apoptosis-inducing factor in ischemic neuronal injury. J Neurosci. 2007;27(35): 9278-9293.
13. Gonzalez-Zulueta M, Ensz LM, Mukhina G, et al. Manganese superoxide dismutase protects nNOS neurons from NMDA and nitric oxide-mediated neurotoxicity. J Neurosci. 1998;18(6):2040-2055.
14. Tenneti L, Lipton SA. Involvement of activated caspase-3-like proteases in N-methyl-D-aspartate-induced apoptosis in cerebrocortical neurons. J Neurochem. 2000;74(1):134-142.
15. Mazumder S, Plesca D, Almasan A. Caspase-3 activation is a critical determinant of genotoxic stress-induced apoptosis. Methods Mol Biol. 2008;414:13-21.
16. Pellegrini JW, Lipton SA. Delayed administration of memantine prevents N-methyl-D-aspartate receptor-mediated neurotoxicity. Ann Neurol. 1993;33(4): 403-407.
17. Smith M, Wells J, Borrie M. Treatment effect size of memantine therapy in Alzheimer disease and vascular dementia. Alzheimer Dis Assoc Disord. 2006;20(3): 133-137.
18. Simoni E, Daniele S, Bottegoni G, et al. Combining galantamine and memantine in multitargeted, new chemical entities potentially useful in Alzheimer's disease. J Med Chem. 2012;55(22):9708-9721.
19. Han HJ, Kim BC, Lee JY, et al. Response to rivastigmine transdermal patch or memantine plus rivastigmine patch is affected by apolipoprotein E genotype in Alzheimer patients. Dement Geriatr Cogn Disord. 2012;34(3-4): 167-173.
20. Danysz W, Parsons CG. Alzheimer's disease, beta-amyloid, glutamate, NMDA receptors and memantine--searching for the connections. Br J Pharmacol. 2012;167(2):324-352.
21. Hellweg R, Wirth Y, Janetzky W, et al. Efficacy of memantine in delaying clinical worsening in Alzheimer's disease (AD): responder analyses of nine clinical trials with patients with moderate to severe AD. Int J Geriatr Psychiatry. 2012;27(6):651-656.
22. Jeong GS, Li B, Lee DS, et al. Cytoprotective and anti-inflammatory effects of spinasterol via the induction of heme oxygenase-1 in murine hippocampal and microglial cell lines. Int Immunopharmacol. 2010;10(12):1587-1594.
23. Donovan L, Welford SM, Haaga J, et al. Hypoxia--implications for pharmaceutical developments. Sleep Breath. 2010;14(4):291-298.
24. Kaizaki A, Tanaka S, Ishige K, et al. The neuroprotective effect of heme oxygenase (HO) on oxidative stress in HO-1 siRNA-transfected HT22 cells. Brain Res. 2006; 1108(1):39-44.
25. Atlante A, Calissano P, Bobba A, et al. Glutamate neurotoxicity, oxidative stress and mitochondria. FEBS Lett. 2001;497(1):1-5.
26. Liu J, Rasul I, Sun Y, et al. GRK5 deficiency leads to reduced hippocampal acetylcholine level via impaired presynaptic M2/M4 autoreceptor desensitization. J Biol Chem. 2009;284(29):19564-19571.
27. Clement AB, Gimpl G, Behl C. Oxidative stress resistance in hippocampal cells is associated with altered membrane fluidity and enhanced nonamyloidogenic cleavage of endogenous amyloid precursor protein. Free Radic Biol Med. 2010;48(9):1236-1241.
28. Yang EJ, Lee JY, Park SH, et al. Neuroprotective effects of neolignans isolated from Magnoliae Cortex against glutamate-induced apoptotic stimuli in HT22 cells. Food Chem Toxicol. in press.
29. Brossaud J, Roumes H, Moisan MP, et al. Retinoids and glucocorticoids target common genes in hippocampal HT22 cells. J Neurochem. in press.
30. Bonfiglio JJ, Inda C, Senin S, et al. B-Raf and CRHR1 internalization mediate biphasic ERK1/2 activation by CRH in hippocampal HT22 cells. Mol Endocrinol. 2013; 27(3):491-510.
31. Davis JB, Maher P. Protein kinase C activation inhibits glutamate-induced cytotoxicity in a neuronal cell line. Brain Res. 1994;652(1):169-173.
32. Murphy TH, Miyamoto M, Sastre A, et al. Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. Neuron. 1989;2(6): 1547-1558.
33. Miyamoto M, Murphy TH, Schnaar RL, et al. Antioxidants protect against glutamate-induced cytotoxicity in a neuronal cell line. J Pharmacol Exp Ther. 1989;250(3): 1132-1140.
34. Sagara Y, Dargusch R, Chambers D, et al. Cellular mechanisms of resistance to chronic oxidative stress. Free Radic Biol Med. 1998;24(9):1375-1389.
35. Levinthal DJ, Defranco DB. Reversible oxidation of ERK-directed protein phosphatases drives oxidative toxicity in neurons. J Biol Chem. 2005;280(7): 5875-5883.
36. Luo Y, DeFranco DB. Opposing roles for ERK1/2 in neuronal oxidative toxicity: distinct mechanisms of ERK1/2 action at early versus late phases of oxidative stress. J Biol Chem. 2006;281(24):16436-16442.
37. Teepker M, Anthes N, Fischer S, et al. Effects of oxidative challenge and calcium on ATP-levels in neuronal cells. Neurotoxicology. 2007;28(1):19-26.
38. Fukui M, Song JH, Choi J, et al. Mechanism of glutamate-induced neurotoxicity in HT22 mouse hippocampal cells. Eur J Pharmacol. 2009;617(1-3):1-11.
39. Kim H, Choi J, Ryu J, et al. Activation of autophagy during glutamate-induced HT22 cell death. Biochem Biophys Res Commun. 2009;388(2):339-344.
40. Yoon SW, Kang S, Ryu SE, et al. Identification of tyrosine-nitrated proteins in HT22 hippocampal cells during glutamate-induced oxidative stress. Cell Prolif. 2010;43(6):584-593.
41. Zhao ZY, Luan P, Huang SX, et al. Edaravone protects HT22 neurons from H(2)O(2)-induced apoptosis by inhibiting the MAPK signaling pathway. CNS Neurosci Ther. 2013;19(3):163-169.
42. Liu J, Li L, Suo WZ. HT22 hippocampal neuronal cell line possesses functional cholinergic properties. Life Sci. 2009;84(9-10):267-271.
43. Zhang Y, Bhavnani BR. Glutamate-induced apoptosis in neuronal cells is mediated via caspase-dependent and independent mechanisms involving calpain and caspase-3 proteases as well as apoptosis inducing factor (AIF) and this process is inhibited by equine estrogens. BMC Neurosci. 2006;7:49.
44. Bhavnani BR, Berco M, Binkley J. Equine estrogens differentially prevent neuronal cell death induced by glutamate. J Soc Gynecol Investig. 2003;10(5):302-308.
45. Fang JH, Wang XH, Xu ZR, et al. Neuroprotective effects of bis(7)-tacrine against glutamate-induced retinal ganglion cells damage. BMC Neurosci. 2010;11:31.
46. Parsons CG, Gruner R, Rozental J, et al. Patch clamp studies on the kinetics and selectivity of N-methyl-D-aspartate receptor antagonism by memantine (1-amino-3,5-dimethyladamantan). Neuropharmacology. 1993;32(12):1337-1350.
47. Levy DI, Lipton SA. Comparison of delayed administration of competitive and uncompetitive antagonists in preventing NMDA receptor-mediated neuronal death. Neurology. 1990;40(5):852-855.
48. Plaitakis A, Caroscio JT. Abnormal glutamate metabolism in amyotrophic lateral sclerosis. Ann Neurol. 1987;22(5): 575-579.
49. Huang YJ, Lin CH, Lane HY, et al. NMDA neurotransmission dysfunction in behavioral and psychological symptoms of Alzheimer's disease. Curr Neuropharmacol. 2012;10(3):272-285.
50. Chen KH, Reese EA, Kim HW, et al. Disturbed neurotransmitter transporter expression in Alzheimer's disease brain. J Alzheimers Dis. 2011;26(4):755-766.
51. Gladding CM, Raymond LA. Mechanisms underlying NMDA receptor synaptic/extrasynaptic distribution and function. Mol Cell Neurosci. 2011;48(4):308-320.
52. Schubert D, Kimura H, Maher P. Growth factors and vitamin E modify neuronal glutamate toxicity. Proc Natl Acad Sci U S A. 1992;89(17):8264-8267.
53. Suo Z, Wu M, Citron BA, et al. Rapid tau aggregation and delayed hippocampal neuronal death induced by persistent thrombin signaling. J Biol Chem. 2003;278(39): 37681-37689.
54. Rabe TI, Griesel G, Blanke S, et al. The transcription factor Uncx4.1 acts in a short window of midbrain dopaminergic neuron differentiation. Neural Dev. 2012;7: 39.
55. Belinsky GS, Sirois CL, Rich MT, et al. Dopamine receptors in human embryonic stem cell neurodifferentiation. Stem Cells Dev. in press.
56. De la Rossa A, Bellone C, Golding B, et al. In vivo reprogramming of circuit connectivity in postmitotic neocortical neurons. Nat Neurosci. 2013;16(2):193-200.
57. Sun AX, Crabtree GR, Yoo AS. MicroRNAs: regulators of neuronal fate. Curr Opin Cell Biol. in press.
58. Bratzler DW, Oehlert WH, McAdams LM, et al. Management of acute exacerbations of chronic obstructive pulmonary disease in the elderly: physician practices in the community hospital setting. J Okla State Med Assoc. 2004;97(6):227-232.
59. Shariati SA, Lau P, Hassan BA, et al. APLP2 regulates neuronal stem cell differentiation during cortical development. J Cell Sci. in press.
60. Schultz KM, Banisadr G, Lastra RO, et al. Geminin-deficient neural stem cells exhibit normal cell division and normal neurogenesis. PLoS One. 2011;6(3): e17736.
61. Ozolek JA, Jane EP, Esplen JE, et al. In vitro neural differentiation of human embryonic stem cells using a low-density mouse embryonic fibroblast feeder protocol. Methods Mol Biol. 2010;584:71-95.
62. Cheng S, Li L, He S, et al. GRK5 deficiency accelerates {beta}-amyloid accumulation in Tg2576 mice via impaired cholinergic activity. J Biol Chem. 2010;285(53): 41541-41548.